{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:33:22Z","timestamp":1793727202064,"version":"4.6.1"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"am","delay-in-days":317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM140154"],"award-info":[{"award-number":["R01GM140154"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 AI108197"],"award-info":[{"award-number":["RO1 AI108197"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI171292"],"award-info":[{"award-number":["U19AI171292"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.antiviral.2022.105360","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T21:57:27Z","timestamp":1654811847000},"page":"105360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Conserved coronavirus proteins as targets of broad-spectrum antivirals"],"prefix":"10.1016","volume":"204","author":[{"given":"Cleber C.","family":"Melo-Filho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesia","family":"Bobrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holli-Joi","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Sessions","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin I.","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel J.","family":"Moorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph S.","family":"Baric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4616-7036","authenticated-orcid":false,"given":"Eugene N.","family":"Muratov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Tropsha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2022.105360_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2022.105360_bib2","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2022.105360_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijid.2020.02.018","article-title":"Discovery and development of safe-in-man broad-spectrum antiviral agents","volume":"93","author":"Andersen","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105360_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.02217-16","article-title":"Binding of the methyl donor S -adenosyl- l -methionine to Middle East respiratory syndrome coronavirus 2\u2032- O -methyltransferase nsp16 promotes recruitment of the allosteric activator nsp10","volume":"91","author":"Aouadi","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105360_bib5","doi-asserted-by":"crossref","first-page":"D115","DOI":"10.1093\/nar\/gkh131","article-title":"UniProt: the universal protein knowledgebase","volume":"32","author":"Apweiler","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2022.105360_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253364","article-title":"Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies","volume":"16","author":"Armstrong","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2022.105360_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.dsx.2020.04.020","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response","volume":"14","author":"Astuti","year":"2020","journal-title":"Diabetes Metabol. Syndr.: Clin. Res. Rev."},{"key":"10.1016\/j.antiviral.2022.105360_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/1348-0421.12828","article-title":"Antiviral activities of mycophenolic acid and IMD-0354 against SARS-CoV-2","volume":"64","author":"F","year":"2020","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2022.105360_bib9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/1753-0407.13052","article-title":"COVID\u201019 and comorbidities: a role for dipeptidyl peptidase 4 (DPP4) in disease severity?","volume":"12","author":"Bassendine","year":"2020","journal-title":"J. Diabetes"},{"key":"10.1016\/j.antiviral.2022.105360_bib10","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","author":"Bateman","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2022.105360_bib11","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 \u2014 final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2022.105360_bib12","first-page":"1","article-title":"Substrate specificity of SARS-CoV-2 nsp10-nsp16 methyltransferase Roberto","volume":"21","author":"Benoni","year":"2020","journal-title":"bioRxiv : the preprint server for biology"},{"key":"10.1016\/j.antiviral.2022.105360_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2022.105360_bib14","first-page":"1","article-title":"Learning from history: do not flatten the curve of antiviral research","author":"Bobrowski","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.antiviral.2022.105360_bib15","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ymthe.2020.12.016","article-title":"Synergistic and antagonistic drug combinations against SARS-CoV-2","volume":"29","author":"Bobrowski","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2022.105360_bib16","series-title":"Discovery of a Novel Inhibitor of Coronavirus 3CL Protease as a Clinical Candidate for the Potential Treatment of COVID-19. bioRxiv : the Preprint Server for Biology","author":"Boras","year":"2020"},{"key":"10.1016\/j.antiviral.2022.105360_bib17","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/092986708784049658","article-title":"Arbidol: a broad-spectrum antiviral compound that blocks viral fusion","volume":"15","author":"Boriskin","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.antiviral.2022.105360_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/a0dde376-2eb1-4ce3-8887-d29f5ba6f162","article-title":"In vitro reconstitution of SARS-coronavirus mRNA cap methylation","volume":"6","author":"Bouvet","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105360_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104541","article-title":"Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase","volume":"169","author":"Brown","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105360_bib20","series-title":"14th community wide experiment on the critical assessment of techniques for protein structure prediction [WWW Document]","year":"2020"},{"key":"10.1016\/j.antiviral.2022.105360_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.138882","article-title":"COVID-19 outbreak: migration, effects on society, global environment and prevention","volume":"728","author":"Chakraborty","year":"2020","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.antiviral.2022.105360_bib22","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jinf.2013.09.029","article-title":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus","volume":"67","author":"Chan","year":"2013","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2022.105360_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcv.2004.03.003","article-title":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds","volume":"31","author":"Chen","year":"2004","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2022.105360_bib24","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1128\/JVI.79.11.7095-7103.2005","article-title":"Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro","volume":"79","author":"Chen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105360_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2014.12.011","article-title":"Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus","volume":"115","author":"Cheng","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105360_bib26","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1021\/acs.jcim.1c00449","article-title":"Dynamic profiling of \u03b2-coronavirus 3CL M pro protease ligand-binding sites","volume":"61","author":"Cho","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.antiviral.2022.105360_bib27","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.bcp.2008.01.005","article-title":"Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus","volume":"75","author":"Chou","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2022.105360_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro","volume":"178","author":"Choy","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105360_bib29","series-title":"Advances in Virus Research","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.aivir.2018.01.001","article-title":"Hosts and sources of endemic human coronaviruses","author":"Corman","year":"2018"},{"key":"10.1016\/j.antiviral.2022.105360_bib32","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00705-020-04628-0","article-title":"The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century","volume":"165","author":"da Costa","year":"2020","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2022.105360_bib33","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1128\/AAC.03011-14","article-title":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture","volume":"58","author":"de Wilde","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2022.105360_bib34","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"117","author":"de Wit","year":"2020","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.antiviral.2022.105360_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002059","article-title":"Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2\u2032-O-methyltransferase nsp10\/nsp16 complex","volume":"7","author":"Decroly","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105360_bib36","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105360_bib37","first-page":"2c00003","article-title":"Allosteric site of ACE-2 as a drug target for COVID-19","author":"Dutta","year":"2022","journal-title":"ACS Pharm. Translat. Sci. acsptsci"},{"key":"10.1016\/j.antiviral.2022.105360_bib38","doi-asserted-by":"crossref","first-page":"26915","DOI":"10.1073\/pnas.2001046117","article-title":"Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection","volume":"117","author":"Edwards","year":"2020","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.antiviral.2022.105360_bib39","series-title":"Coronaviruses: Methods and Protocols, Methods in Molecular Biology","first-page":"1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","author":"Fehr","year":"2015"},{"key":"10.1016\/j.antiviral.2022.105360_bib40","series-title":"Molnupiravir, an Oral Antiviral Treatment for COVID-19. medRxiv : the Preprint Server for Health Sciences","author":"Fischer","year":"2021"},{"key":"10.1016\/j.antiviral.2022.105360_bib41","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1038\/s41467-020-18233-x","article-title":"Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease","volume":"11","author":"Fu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105360_bib42","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.immuni.2020.04.016","article-title":"SARS-CoV-2: combating coronavirus emergence","volume":"52","author":"Graham","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2022.105360_bib43","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2002324118","article-title":"Ranking the risk of animal-to-human spillover for newly discovered viruses","volume":"118","author":"Grange","year":"2021","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.antiviral.2022.105360_bib44","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1359-6446(04)03196-4","article-title":"Utility of homology models in the drug discovery process","volume":"9","author":"Hillisch","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.antiviral.2022.105360_bib45","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-75474-1_4","article-title":"Priming time: how cellular proteases arm coronavirus spike proteins","volume":"71","author":"Hoffmann","year":"2018","journal-title":"Activat. Viruses Host Proteases"},{"key":"10.1016\/j.antiviral.2022.105360_bib46","article-title":"Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture","author":"Hu","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.antiviral.2022.105360_bib47","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jiph.2021.06.013","article-title":"Trends in the development of remdesivir based inventions against COVID-19 and other disorders: a patent review","volume":"14","author":"Imran","year":"2021","journal-title":"J. Infection Public Health"},{"key":"10.1016\/j.antiviral.2022.105360_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pbio.1002452","article-title":"Functional sites induce long-range evolutionary Constraints in enzymes","volume":"14","author":"Jack","year":"2016","journal-title":"PLoS Biol."},{"key":"10.1016\/j.antiviral.2022.105360_bib49","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021579118","article-title":"Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection","volume":"118","author":"Jan","year":"2021","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.antiviral.2022.105360_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00819-20","article-title":"Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs","volume":"64","author":"Jeon","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2022.105360_bib51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105360_bib52","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1471-2164-8-222","article-title":"Quantitative assessment of relationship between sequence similarity and function similarity","volume":"8","author":"Joshi","year":"2007","journal-title":"BMC Genom."},{"key":"10.1016\/j.antiviral.2022.105360_bib53","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105360_bib54","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","article-title":"Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis","volume":"28","author":"Kabinger","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2022.105360_bib55","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virusres.2012.10.018","article-title":"Ribavirin efficiently suppresses porcine nidovirus replication","volume":"171","author":"Kim","year":"2013","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2022.105360_bib56","doi-asserted-by":"crossref","first-page":"11754","DOI":"10.1128\/JVI.01348-12","article-title":"Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses","volume":"86","author":"Kim","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105360_bib57","doi-asserted-by":"crossref","first-page":"11754","DOI":"10.1128\/JVI.01348-12","article-title":"Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses","volume":"86","author":"Kim","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105360_bib58","article-title":"Reversal of the progression of fatal coronavirus infection in Cats by a broad-spectrum coronavirus protease inhibitor","volume":"12","author":"Kim","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105360_bib59","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s42003-021-01735-9","article-title":"Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2","volume":"4","author":"Kim","year":"2021","journal-title":"Communications Biology"},{"key":"10.1016\/j.antiviral.2022.105360_bib60","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41467-020-20542-0","article-title":"Mechanism of SARS-CoV-2 polymerase stalling by remdesivir","volume":"12","author":"Kokic","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105360_bib61","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1038\/s41467-020-17495-9","article-title":"Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin","volume":"11","author":"Krafcikova","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105360_bib62","author":"Kuzikov"},{"key":"10.1016\/j.antiviral.2022.105360_bib63","first-page":"8638","article-title":"Genetic characterization of betacoronavirus lineage C viruses in bats reveals marked sequence Divergence in the spike protein of Pipistrellus bat coronavirus HKU5 in Japanese pipistrelle : implications for the origin of the novel Middle East","volume":"87","author":"Lau","year":"2013","journal-title":"Respiratory"},{"key":"10.1016\/j.antiviral.2022.105360_bib64","series-title":"Emergence of Porcine Delta-Coronavirus Pathogenic Infections Among Children in Haiti through Independent Zoonoses and Convergent Evolution. medRxiv : the Preprint Server for Health Sciences","author":"Lednicky","year":"2021"},{"key":"10.1016\/j.antiviral.2022.105360_bib65","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.bmc.2019.03.050","article-title":"Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via high-throughput screening and molecular modeling","volume":"27","author":"Lee","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2022.105360_bib66","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Ann. Rev. Virol."},{"key":"10.1016\/j.antiviral.2022.105360_bib67","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.antiviral.2017.12.015","article-title":"Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes","volume":"150","author":"Lin","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105360_bib68","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41392-020-00241-4","article-title":"Crystal structure of SARS-CoV-2 nsp10\/nsp16 2\u2032-O-methylase and its implication on antiviral drug design","volume":"5","author":"Lin","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.antiviral.2022.105360_bib69","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","article-title":"Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2022.105360_bib70","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/nm.3985","article-title":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence","volume":"21","author":"Menachery","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2022.105360_bib71","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/v9120364","article-title":"Identification of alpha and beta coronavirus in wildlife species in France: bats, rodents, rabbits, and hedgehogs","volume":"9","author":"Monchatre-Leroy","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2022.105360_bib72","series-title":"Viribus Unitis: Drug Combinations as a Treatment against COVID-19. ChemRxiv : the Preprint Server for Chemistry","author":"Muratov","year":"2020"},{"key":"10.1016\/j.antiviral.2022.105360_bib73","doi-asserted-by":"crossref","first-page":"9121","DOI":"10.1039\/D0CS01065K","article-title":"A critical overview of computational approaches employed for COVID-19 drug discovery","volume":"50","author":"Muratov","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.antiviral.2022.105360_bib76","series-title":"READDI, Aims to Invest $125 Million to Prevent Future Pandemics [WWW Document]","year":"2020"},{"key":"10.1016\/j.antiviral.2022.105360_bib77","doi-asserted-by":"crossref","DOI":"10.1177\/2472555220985040","article-title":"A high-throughput RNA Displacement assay for screening SARS-CoV-2 nsp10-nsp16 complex toward developing therapeutics for COVID-19","author":"Perveen","year":"2021","journal-title":"SLAS DISCOVERY: Adv. Sci. Drug Discov."},{"key":"10.1016\/j.antiviral.2022.105360_bib78","series-title":"Human Herpesviruses Biology, Therapy, and Immunoprophylaxis","article-title":"New approaches to antiviral drug discovery (genomics\/proteomics)","author":"Prichard","year":"2007"},{"key":"10.1016\/j.antiviral.2022.105360_bib80","doi-asserted-by":"crossref","first-page":"11892","DOI":"10.1073\/pnas.0601708103","article-title":"Crystal structure and mechanistic determinants of SARS coronavirus nonstructural protein 15 define an endoribonuclease family","volume":"103","author":"Ricagno","year":"2006","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.antiviral.2022.105360_bib81","doi-asserted-by":"crossref","first-page":"W320","DOI":"10.1093\/nar\/gku316","article-title":"Deciphering key features in protein structures with the new ENDscript server","volume":"42","author":"Robert","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2022.105360_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abe1202","article-title":"High-resolution structures of the SARS-CoV-2 2\u2032-O-methyltransferase reveal strategies for structure-based inhibitor design","volume":"13","author":"Rosas-Lemus","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.antiviral.2022.105360_bib83","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: a first-in-class broad-spectrum antiviral agent","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105360_bib84","series-title":"Activity Profiling and Structures of Inhibitor-Bound SARS-CoV-2-PLpro Protease Provides a Framework for Anti-COVID-19 Drug Design. bioRxiv : the Preprint Server for Biology 1\u201318","author":"Rut","year":"2020"},{"key":"10.1016\/j.antiviral.2022.105360_bib85","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.antiviral.2005.01.003","article-title":"Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus","volume":"66","author":"Saijo","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105360_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyg.2020.577684","article-title":"The psychological and social impact of Covid-19: new perspectives of well-being","volume":"11","author":"Saladino","year":"2020","journal-title":"Front. Psychol."},{"key":"10.1016\/j.antiviral.2022.105360_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104793","article-title":"Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites","volume":"178","author":"Shannon","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105360_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004457","article-title":"Emergence of MERS-CoV in the Middle East: origins, transmission, treatment, and perspectives","volume":"10","author":"Sharif-Yakan","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105360_bib89","doi-asserted-by":"crossref","first-page":"eaal3653","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2022.105360_bib90","doi-asserted-by":"crossref","first-page":"eabb5883","DOI":"10.1126\/scitranslmed.abb5883","article-title":"An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice","volume":"12","author":"Sheahan","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2022.105360_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high\u2010quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.antiviral.2022.105360_bib92","unstructured":"Spillover [WWW Document], n.d. URL https:\/\/spillover.global\/ranking-comparison\/(accessed 8.12.21)."},{"key":"10.1016\/j.antiviral.2022.105360_bib93","article-title":"6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro protease activities","author":"Swaim","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.antiviral.2022.105360_bib94","series-title":"Pfizer, in a Rare COVID-19 Setback, Dumps Paxlovid's Intravenous Sibling in Further Blow to ACTIV-3 [WWW Document]","author":"Taylor","year":"2022"},{"key":"10.1016\/j.antiviral.2022.105360_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104697","article-title":"In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus","volume":"174","author":"Theerawatanasirikul","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105360_bib96","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.micinf.2020.04.002","article-title":"Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses","volume":"22","author":"Tilocca","year":"2020","journal-title":"Microb. Infect."},{"key":"10.1016\/j.antiviral.2022.105360_bib97","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/17460441.2019.1581171","article-title":"Broad-spectrum coronavirus antiviral drug discovery","volume":"14","author":"Totura","year":"2019","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.antiviral.2022.105360_bib98","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrmicro3475","article-title":"Broad-spectrum antivirals against viral fusion","volume":"13","author":"Vigant","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2022.105360_bib99","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V\u2019kovski","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2022.105360_bib100","first-page":"2019","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2022.105360_bib101","author":"WHO"},{"key":"10.1016\/j.antiviral.2022.105360_bib102","author":"WHO"},{"key":"10.1016\/j.antiviral.2022.105360_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-021-02783-1","article-title":"How antiviral pill molnupiravir shot ahead in the COVID drug hunt","author":"Willyard","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105360_bib105","series-title":"Nelfinavir Is Active against SARS-CoV-2 in Vero E6 Cells. ChemRxiv : the Preprint Server for Chemistryiv","author":"Xu","year":"2020"},{"key":"10.1016\/j.antiviral.2022.105360_bib106","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/med.21763","article-title":"Drug repurposing approach to combating coronavirus: potential drugs and drug targets","volume":"41","author":"Xu","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2022.105360_bib107","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bbrc.2004.04.083","article-title":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus","volume":"318","author":"Yamamoto","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2022.105360_bib108","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.2174\/138161206779010369","article-title":"Drug design targeting the main protease, the achilles heel of coronaviruses","volume":"12","author":"Yang","year":"2006","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.antiviral.2022.105360_bib109","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1021\/acs.jproteome.1c00206","article-title":"Genetic variability of the SARS-CoV-2 pocketome","volume":"20","author":"Yazdani","year":"2021","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.antiviral.2022.105360_bib110","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.1021\/acs.jmedchem.9b00781","article-title":"Design, synthesis, and anti-RNA virus activity of 6\u2032-fluorinated-aristeromycin analogues","volume":"62","author":"Yoon","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2022.105360_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105078","article-title":"A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase","volume":"190","author":"Zhao","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105360_bib112","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses \u2014 drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354222001292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354222001292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:35:47Z","timestamp":1759062947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354222001292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":106,"alternative-id":["S0166354222001292"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105360","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2022-zg88d","asserted-by":"object"}]},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conserved coronavirus proteins as targets of broad-spectrum antivirals","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105360"}}